Journal of the American Chemical Society
Communication
Chem. 2011, 7, 1570. (f) Jones, E. P.; Jones, P.; Barrett, A. M. G. Org.
Lett. 2011, 13, 1012.
This work was partially supported by KAKENHI (B) and by a
Grant-in-Aid for JSPS Fellows to K.T.
(14) For pioneering reports on racemic synthesis of α-arylated amino
acid derivatives via Pd-catalyzed arylation of enolates, see: (a) Lee, S.;
Beare, N. A.; Hartwig, J. F. J. Am. Chem. Soc. 2001, 123, 8410.
(b) Gaertzen, O.; Buchwald, S. L. J. Org. Chem. 2002, 67, 465. (c) Liu,
X.; Hartwig, J. F. Org. Lett. 2003, 5, 1915. (d) Hama, T.; Hartwig, J. F.
Org. Lett. 2008, 11, 1549.
(15) A possible explanation for the solvent dependence is as follows:
Deprotonation of 23-I (Scheme 5) is basically preferable to give
enantiomerically enriched enolate D followed by the product with
inversion of configuration. Deprotonation of 23-II seems to be
preferential only in less-coordinative solvents such as toluene because
coordination of the countercation of the base with the urea carbonyl
group would become crucial in a less-coordinative solvent and would
give chiral enolate ent-D followed by the product with retention of
configuration.
REFERENCES
■
(1) For reviews of asymmetric synthesis via MOC, see: (a) Zhao, H.;
Hsu, D. C.; Carlier, P. R. Synthesis 2005, 1. (b) Kawabata, T. ACS Symp.
Ser. 2009, 1009, 31. For the first report of MOC, see: (c) Kawabata, T.;
Yahiro, K.; Fuji, K. J. Am. Chem. Soc. 1991, 113, 9694.
(2) For recent reports on related asymmetric reactions via axially chiral
enolates, see: (a) Ghorai, M. K.; Ghosh, K.; Yadav, A. K.; Nanaji, Y.;
Halder, S.; Sayyad, M. J. Org. Chem. 2013, 78, 2311. (b) Mai, T. T.;
Viswambharan, B.; Gori, D.; Kouklovsky, C.; Alezra, V. J. Org. Chem.
́
2012, 77, 8797. (c) Fletcher, S. P.; Sola, J.; Holt, D.; Brown, R. A.;
Clayden, J. Beilstein. J. Org. Chem. 2011, 7, 1304. (d) Branca, M.; Pena,
S.; Guillot, R.; Gori, D.; Alezra, V.; Kouklovsky, C. J. Am. Chem. Soc.
2009, 131, 10711. (e) Kolaczkowski, L.; Barnes, D. M. Org. Lett. 2007, 9,
3029. (f) MacQuarrie-Hunter, S.; Carlier, P. R. Org. Lett. 2005, 7, 5305.
(g) Carlier, P. R.; Zhao, H.; DeGuzman, J.; Lam, P. C.-H. J. Am. Chem.
Soc. 2003, 125, 11482. (h) Gerona-Navarro, G.; Bonache, M. A.; Hernz,
(16) Coquerel, G.; Petit, S. J. Cryst. Growth 1993, 130, 173.
(17) A conformational search for 23 was performed by a molecular
modeling search (MCMM, 10 000 steps) with the OPLS 2005 force
field using MacroModel (v. 9.0). Conformer 23-I was suggested to be
1.2 kcal/mol less stable than the most stable conformer 23-II. For
details, see the SI.
R.; García-Lop
3538.
́
ez, M. T.; Gonzalez-Muniz, R. J. Org. Chem. 2001, 66,
́
̃
(3) Kawabata, T.; Suzuki, H.; Nagae, Y.; Fuji, K. Angew. Chem., Int. Ed.
2000, 39, 2155.
(4) Yoshimura, T.; Kinoshita, T.; Yoshioka, H.; Kawabata, T. Org. Lett.
(18) For example, see: Stilz, H. U.; Guba, W.; Jablonka, B.; Just, M.;
Klingler, O.; Konig, W.; Wehner, V.; Zoller, G. J. Med. Chem. 2001, 44,
̈
2013, 15, 864.
1158.
(5) Watanabe, H.; Yoshimura, T.; Kawakami, S.; Sasamori, T.;
Tokitoh, N.; Kawabata, T. Chem. Commun. 2012, 48, 5346.
(6) (a) Kawabata, T.; Moriyama, K.; Kawakami, S.; Tsubaki, K. J. Am.
Chem. Soc. 2008, 130, 4153. (b) Yoshimura, T.; Takuwa, M.; Tomohara,
K.; Uyama, M.; Hayashi, K.; Yang, P.; Hyakutake, R.; Sasamori, T.;
Tokitoh, N.; Kawabata, T. Chem.Eur. J. 2012, 18, 15330.
(c) Monguchi, D.; Yoshimura, T.; Irie, K.; Hayashi, K.; Majumdar, S.;
Sasamori, T.; Tokitoh, N.; Kawabata, T. Heterocycles 2012, 86, 1483.
(7) (a) Kawabata, T.; Kawakami, S.; Majumdar, S. J. Am. Chem. Soc.
2003, 125, 13012. (b) Kawabata, T.; Matsuda, S.; Kawakami, S.;
Monguchi, D.; Moriyama, K. J. Am. Chem. Soc. 2006, 128, 15394.
(c) Yoshimura, T.; Tomohara, K.; Kawabata, T. J. Am. Chem. Soc. 2013,
135, 7102.
(19) Amino acid derivatives with an aryl-substituted tetrasubstituted
carbon are a new type of chiral building blocks for drug discovery. For
example, see: Kahlon, D. K.; Lansdell, T. A.; Fisk, J. S.; Tepe, J. J. Bioorg.
Med. Chem. 2009, 17, 3093.
(8) Kawabata, T.; Majumdar, S.; Tsubaki, K.; Monguchi, D. Org.
Biomol. Chem. 2005, 3, 1609.
(9) Teraoka, F.; Fuji, K.; Ozturk, O.; Yoshimura, T.; Kawabata, T.
Synlett 2011, 543.
(10) Attempted intramolecular Pd-catalyzed asymmetric α-arylation
reactions of chiral enolates derived from α-amino acid esters resulted in
low asymmetric induction (up to 32% ee) because of significant
racemization of the chiral enolates during the reactions (data not
shown). Pd-catalyzed arylation reactions of enolates were performed at
rt to 90 °C employing the methods shown in ref 14.
(11) (a) Clayden, J.; Dufour, J.; Grainger, D. M.; Helliwell, M. J. Am.
Chem. Soc. 2007, 129, 7488. For related carbanionic aryl migrations, see:
(b) Clayden, J.; Famaby, W.; Grainger, D. M.; Hennecke, U.; Mancinelli,
M.; Tetlow, D. J.; Hiller, I. H.; Vincent, M. A. J. Am. Chem. Soc. 2009,
131, 3410. (c) Clayden, J.; Donnard, J.; Lefranc, J.; Minassi, A.; Tetlow,
D. J. Am. Chem. Soc. 2010, 132, 6624. (d) Fournier, A. M.; Clayden, J.
Org. Lett. 2012, 14, 142. (e) Tetlow, D. J.; Vincent, M. A.; Hiller, I. H.;
Clayden, J. Chem. Commun. 2013, 49, 1548. (f) Tait, M.; Donnard, M.;
Minassi, A.; Lefranc, J.; Bechi, B.; Carbone, G.; O’Brien, P.; Clayden, J.
Org. Lett. 2013, 15, 34.
(12) For asymmetric arylation of amino acid derivatives by asymmetric
aryl rearrangement of aryl sulfonamides, see: (a) Lupi, V.; Penso, M.;
Foschi, F.; Gassa, F.; Mihali, V.; Tagliabue, A. Chem. Commun. 2009,
5012. (b) Foschi, F.; Landini, D.; Lupi, V.; Mihali, V.; Penso, M.; Pilati,
T.; Tagliabue, A. Chem.Eur. J. 2010, 16, 10667.
(13) For chiral-auxiliary-based asymmetric α-arylation of amino acid
derivatives, see: (a) Tayama, E.; Kimura, H. Angew. Chem., Int. Ed. 2007,
46, 8869. (b) Makosza, M.; Sulikowski, D.; Maltsev, O. Synlett 2008,
1711. (c) Tayama, E.; Orihara, K.; Kimura, H. Org. Biomol. Chem. 2008,
6, 3673. (d) Sulikowski, D.; Makosza, M. Eur. J. Org. Chem. 2010, 4218.
(e) Jones, E. P.; Jones, P.; White, A. J. P.; Barrett, A. G. M. Beilstein J. Org.
D
dx.doi.org/10.1021/ja406653n | J. Am. Chem. Soc. XXXX, XXX, XXX−XXX